The CRO That Solves Oncology Trial Challenges.
Reliable, flexible, and built for global trials — Biorasi brings cancer therapies to patients faster.
Why Biorasi For Oncology?
When cancer trials require strategic precision, sponsors turn to Biorasi. We combine oncology-specific experience, global reach, and agile execution to overcome barriers and hit milestones on time, every time.
Subspecialties
- Solid Tumors
- Hematologic Malignancies
- Rare Cancers
Proof of Performance
- 24 Oncology Studies
- 19 Indications
- 194 Sites Activated
- 1,146 Patients Enrolled
THE BIORASI ADVANTAGE
ONCOLOGY EXPERIENCE
Proven strategies even in rare and hard-to-reach populations
REGULATORY EXPERTISE
Oncology-focused regulatory insights with FDA, EMA, and global compliance
GLOBAL REACH
Access to patients and clinical sites across 48 countries
FROM OUR PARTNERS
Nataliya Agafonova, MD 2
“Working with the Biorasi team was an incredible experience. As our…Read More
Nataliya Agafonova, MD 2
“Working with the Biorasi team was an incredible experience. As our lead CRO, they managed every aspect of our clinical study — from design and conduct to monitoring, data management, and final data delivery.”
Nataliya Agafonova, MD
Chief Medical Officer, Longeveron Inc.
From the Library
Article
Biorasi Center of Excellence Spotlight: Oncology
Article
Biorasi Meets First Patient, First Visit Milestone for Dermatology Trial During COVID-19
Article
Biorasi Kicks-Off Third COVID-19 Clinical Trial for 2020
Article